共 253 条
[1]
McKenna LR(2014)Update on pancreatic neuroendocrine tumors Gland Surg. 3 258-275
[2]
Edil BH(2008)One hundred years after ”carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol. 26 3063-3072
[3]
Yao JC(2007)Plasminogen activator inhibitor-1 in vascular thrombosis Curr Drug Targets. 8 966-1002
[4]
Hassan M(2011)The epidemiology of gastroenteropancreatic neuroendocrine tumors Endocrinol Metab Clin North Am. 40 1-18
[5]
Phan A(2010)Pancreatic endocrine tumors: radiologic-clinicopathologic correlation Radiographics. 30 1445-1464
[6]
Dagohoy C(2016)ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors Neuroendocrinology. 103 153-171
[7]
Leary C(2012)Pathology - grading and staging of GEP-NETs Best Pract Res Clin Gastroenterol. 26 705-717
[8]
Mares JE(2012)Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000–2009: multicenter study Cancer Res Treat. 44 157-165
[9]
Westrick RJ(2008)Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival Ann Oncol. 19 1727-1733
[10]
Eitzman DT(2018)Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors Journal of nuclear medicine. 59 66-74